MedPath

desmopressin acetate

Desmopressin Acetate Injection, USPFor Intravenous or Subcutaneous Use Only

Approved
Approval ID

40752c75-d09b-4013-9024-442048145b63

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 14, 2020

Manufacturers
FDA

Sagent Pharmaceuticals

DUNS: 796852890

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

desmopressin acetate

PRODUCT DETAILS

NDC Product Code25021-461
Application NumberANDA204751
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, SUBCUTANEOUS
Effective DateAugust 14, 2020
Generic Namedesmopressin acetate

INGREDIENTS (4)

hydrochloric acidInactive
Code: QTT17582CB
Classification: IACT
chlorobutanolInactive
Code: HM4YQM8WRC
Classification: IACT
sodium chlorideInactive
Code: 451W47IQ8X
Classification: IACT
desmopressin acetateActive
Quantity: 40 ug in 10 mL
Code: XB13HYU18U
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

desmopressin acetate - FDA Drug Approval Details